(Q35238510)

7 August 2017

1 reference

title

Vitamin D3 and skin diseases (English)

1 reference

7 August 2017

1 reference

K. Kragballe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1337425

15 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1337425

15 September 2022

publication date

1 January 1992

1 reference

Archives of Dermatological Research

7 August 2017

published in

1 reference

7 August 2017

volume

284 Suppl 1

1 reference

7 August 2017

page(s)

S30-6

1 reference

1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro

7 August 2017

cites work

1 reference

12 December 2020

Expression of 1,25-Dihydroxyvitamin D3 Receptors in Normal and Psoriatic Skin

1 reference

12 December 2020

Calcipotriol and hypercalcaemia

1 reference

12 December 2020

A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis

1 reference

12 December 2020

1 alpha,25(OH)2 vitamin D3 increases intracellular calcium in human keratinocytes

1 reference

12 December 2020

Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.

1 reference

12 December 2020

Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions

1 reference

12 December 2020

Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3.

1 reference

12 December 2020

Vitamin D metabolism in psoriasis before and after phototherapy

1 reference

12 December 2020

Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid

1 reference

12 December 2020

Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study

1 reference

12 December 2020

1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production

1 reference

12 December 2020

Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes

1 reference

12 December 2020

1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes

1 reference

12 December 2020

Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.

1 reference

12 December 2020

Inverse relation between severity of psoriasis and serum 1,25-dihydroxy-vitamin D level

1 reference

12 December 2020

Psoriasis exacerbated by hypoparathyroidism with hypocalcaemia

1 reference

12 December 2020

Efficacy of 1, alpha 25-dihidroxyvitamin D (Calcitriol) in the treatment of psoriasis vulgaris: an open study

1 reference

12 December 2020

1,24(R)-dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity

1 reference

12 December 2020

Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)

1 reference

12 December 2020

Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies

1 reference

12 December 2020

Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis

1 reference

12 December 2020

Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.

1 reference

12 December 2020

Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study

1 reference

12 December 2020

Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue

1 reference

12 December 2020

Interaction of 1,25-Dihydroxyvitamin-D3with Keratinocytes and Fibroblasts from Skin of Normal Subjects and a Subject with Vitamin-D-Dependent Rickets, Type II: A Model for Study of the Mode of Action of 1,25-Dihydroxyvitamin D3*

1 reference

12 December 2020

Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study

1 reference

12 December 2020

Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3

1 reference

12 December 2020

Abnormal vitamin D metabolism in patients with psoriasis.

1 reference

12 December 2020

Comparative effects of a novel vitamin D analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture

1 reference

12 December 2020

Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo

1 reference

12 December 2020

Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes

1 reference

12 December 2020

Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1 alpha,24-dihydroxycholecalciferol

1 reference

12 December 2020

Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells

1 reference

12 December 2020

A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3

1 reference

12 December 2020

20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses

1 reference

12 December 2020

A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis

1 reference

12 December 2020

Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris

1 reference

12 December 2020

Agonist/inositol trisphosphate-induced release of calcium from murine keratinocytes: a possible link with keratinocyte differentiation.

1 reference

12 December 2020

Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3*

1 reference

12 December 2020

A double-blind, placebo-controlled trial of topical I,25-dihydroxycholecalciferol in psoriasis

1 reference

12 December 2020

Hypocalcemia-induced pustular psoriasis of von Zumbusch. New experience with an old syndrome

1 reference

12 December 2020

Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin

1 reference

12 December 2020

Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium

1 reference

12 December 2020

Vitamin D receptors: nature and function

1 reference

12 December 2020

Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts

1 reference

12 December 2020

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00638238

1 reference

7 August 2017

1 reference